Pramipexole Dihydrochloride (Mirapex) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 23, 2026
Some Pramipexole Dihydrochloride products are in shortage in Canada (4 of 40 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
A dopamine agonist used to treat Parkinson's disease and restless legs syndrome.
Products affected
4 / 40
In shortage since
Feb 4, 2026
Est. full return
Sep 4, 2026
Reports on file
135
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-PRAMIPEXOLE
1.5MG · TABLET · APOTEX INC
DIN 02292408 · since Mar 3, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-PRAMIPEXOLE
0.25MG · TABLET · APOTEX INC
DIN 02292378 · since Jun 16, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-PRAMIPEXOLE
0.5MG · TABLET · APOTEX INC
DIN 02292386 · since Jun 2, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACT PRAMIPEXOLE
0.25MG · TABLET · TEVA CANADA LIMITED
DIN 02297302 · since Feb 4, 2026, no end estimate · Disruption of the manufacture of the drug.
DIN 02297256 · ended May 8, 2026 · Disruption of the manufacture of the drug.
Resolved
ACT PRAMIPEXOLE
1.5MG · TABLET · TEVA CANADA LIMITED
DIN 02297337 · ended Oct 1, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
0.5MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02309130 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
0.25MG · TABLET · SANIS HEALTH INC
DIN 02367602 · ended Apr 24, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
1.5MG · TABLET · PRO DOC LIMITEE
DIN 02325837 · ended Apr 16, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ PRAMIPEXOLE
1MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02315289 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ PRAMIPEXOLE
0.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02315270 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Pramipexole Dihydrochloride is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Pramipexole Dihydrochloride is classified under “DOPAMINERGIC AGENTS” (ATC N04BC).
Recent changes
Jul 23, 2026
Estimated end date pushed back : Aug 14, 2026 → Aug 28, 2026
Common questions
What is Pramipexole Dihydrochloride used for?
A dopamine agonist used to treat Parkinson's disease and restless legs syndrome.
When will Pramipexole Dihydrochloride be back in stock in Canada?
The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Pramipexole Dihydrochloride in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.